Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKTX | AMGN | GILD | CELG | ILMN |
| Company | Akari Therapeutics ADR | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.5500 | 312.89 | 64.72 | 108.01 | 111.35 |
| High | 1.6500 | 314.89 | 66.20 | 108.59 | 112.24 |
| Low | 1.5500 | 309.82 | 64.67 | 107.27 | 109.53 |
| Last | 1.6000 | 310.15 | 65.96 | 108.24 | 110.53 |
| Change | -0.0350 | -2.71 | +1.38 | +0.11 | -0.82 |
| % Change | -2.14% | -0.87% | +2.14% | +0.10% | -0.74% |
| Volume | 19,000 | 2,611,800 | 8,733,200 | 191,230,496 | 1,179,700 |
| 20-Day Average Volume | 23,165 | 2,930,860 | 7,614,375 | 16,188,930 | 1,625,610 |
| Previous Close | 1.6350 | 312.86 | 64.58 | 108.13 | 111.35 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3316 | 281.61 | 65.99 | 108.17 | 119.04 |
| 20-Day Raw Stochastic | 66.13% | 79.89% | 39.52% | 63.25% | 10.08% |
| 20-Day Relative Strength | 51.70% | 65.95% | 39.82% | 64.69% | 35.33% |
| Weighted Alpha | -55.08 | +34.03 | -19.29 | +46.30 | -45.62 |
| Today's Opinion | 72% Sell | 56% Buy | 100% Sell | 100% Buy | 88% Sell |
| Previous Opinion | 72% Sell | 56% Buy | 100% Sell | 100% Buy | 88% Sell |
| Last Month's Opinion | 100% Sell | 40% Sell | 100% Sell | 100% Buy | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +17.65% since 05/03/24 | -0.37% since 05/03/24 | +1.82% since 05/03/24 | -1.97% since 11/13/19 | -6.27% since 05/03/24 |
| Low | 1.1701 on 05/06/24 | 297.52 on 05/06/24 | 64.34 on 05/06/24 | 107.27 on 11/20/19 | 108.54 on 05/08/24 |
| High | 1.7500 on 05/09/24 | 314.89 on 05/10/24 | 66.20 on 05/10/24 | 110.53 on 11/14/19 | 119.43 on 05/07/24 |
| 1-Month | |||||
| %Chg | +23.08% since 04/10/24 | +16.40% since 04/10/24 | -3.17% since 04/10/24 | +5.14% since 10/18/19 | -15.74% since 04/10/24 |
| Low | 1.0775 on 04/17/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 102.40 on 10/21/19 | 108.54 on 05/08/24 |
| High | 1.8676 on 05/02/24 | 322.60 on 05/03/24 | 69.03 on 04/11/24 | 110.70 on 11/13/19 | 134.85 on 04/12/24 |
| 3-Month | |||||
| %Chg | -33.33% since 02/09/24 | +6.54% since 02/09/24 | -10.47% since 02/09/24 | +13.63% since 08/20/19 | -19.81% since 02/09/24 |
| Low | 1.0775 on 04/17/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 93.41 on 08/23/19 | 108.54 on 05/08/24 |
| High | 2.4400 on 03/04/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 110.70 on 11/13/19 | 147.25 on 02/16/24 |
| 6-Month | |||||
| %Chg | -52.66% since 11/10/23 | +16.03% since 11/10/23 | -13.12% since 11/10/23 | +14.14% since 05/20/19 | +12.36% since 11/10/23 |
| Low | 1.0775 on 04/17/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.08 on 07/23/19 | 92.26 on 11/13/23 |
| High | 3.5700 on 11/14/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,955 | 167,829,040 | 80,407,072 | 77,035,920 | 17,738,056 |
| Shares Outstanding, K | 7,924 | 536,435 | 1,245,077 | 711,714 | 159,300 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -10,010,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 6,686,000,000 | 4,520,000,000 | 1,076,000,000 |
| Last Quarter Net Income | -5,680,000 | -113,000,000 | -4,170,000,000 | 1,691,000,000 | -126,000,000 |
| 60-Month Beta | 0.99 | 0.60 | 0.22 | 1.41 | 1.20 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 09/27/22 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 0.09 on 05/02/24 |
| Latest Earnings Date | 05/06/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.50 | 16.11 | 10.99 | 125.70 |